Patent application number | Description | Published |
20090085808 | Microwave communication package - A microwave communication package is constructed on an electrically conducting base plate having a first side defining a base plate cavity, with an antenna apparatus mounted on an opposite, second side. A dielectric substrate on the first side of the base plate covers the base plate cavity; and sealing apparatus contacting the dielectric substrate and the base plate completely around the base plate cavity hermetically seals the cavity. Circuitry mounted on a surface of the substrate within the base plate cavity includes one or more microstrip lines communicating components to one or more waveguides comprising openings extending through the base plate; and the waveguides are coupled at their opposite ends to the antenna apparatus. | 04-02-2009 |
20090179726 | Inductor that contains magnetic field propagation - An inductor and method of containing a magnetic field is provided. The inductor includes a first set of layers wound in a first predetermined direction, wherein each layer of the first set of layers is electrically connected to one another, and a second set of layers wound in a second predetermined direction, wherein each layer of the second set of layers is electrically connected to one another and the first set of layers, and the second set of layers is between a top layer and a bottom layer, such that the top layer forms a first pair with a first layer of the second set of layers, and the bottom layer forms a second pair with a second layer of the second set of layers so that the magnetic field is substantially contained, such as to remain substantially within a gap defined between each layer of the pairs of layers. | 07-16-2009 |
20120013742 | VISION SYSTEM AND METHOD FOR DISPLAYING A FIELD OF VIEW DEPENDENT UPON DETECTING AN OBJECT - A vision system in a vehicle and a method for operating the system. The system displays a field of view that is a portion of an image of an area proximate to the vehicle. The system includes an object detection means that provides an indication of an object being present in the area proximate to the vehicle. The field of view is selected at least in part based on the detection of the object, such as directing the field of view toward the object so the vehicle driver can more easily discern the presence of the object in a display. | 01-19-2012 |
20130127562 | SURFACE MOUNTABLE MICROWAVE SIGNAL TRANSITION BLOCK FOR MICROSTRIP TO PERPENDICULAR WAVEGUIDE TRANSITION - A surface mountable transition block for perpendicular transitions between a microstrip or stripline and a waveguide. The transition block configuration allows for a reduction in the overall cost of a microwave circuit assembly because the circuit board to which the transition block is attached can be an FR-4 type circuit board as opposed to more expensive microwave circuit board materials. | 05-23-2013 |
Patent application number | Description | Published |
20100162593 | DISPLACEMENT-CONTROLLED HYDRAULIC SYSTEM FOR MULTI-FUNCTION MACHINES - A displacement-controlled hydraulic system for installation on a multi-function machine, and multi-function machines equipped with the hydraulic system and having devices for propelling the machine, at least a first implement, and multiple actuators that perform multiple functions of the machine. The multiple actuators include first actuators that control the first implement and second actuators that control the propelling devices. The hydraulic system comprises multiple pumps for controlling the first actuators and optionally the second actuators, and valves that enable at least one of the pumps to sequentially control two of the multiple actuators and a corresponding two functions of the multiple functions performed thereby. None of the pumps sequentially controls the second actuators in combination with any of the first actuators. | 07-01-2010 |
20100162885 | SYSTEM AND METHOD FOR ENABLING FLOATING OF EARTHMOVING IMPLEMENTS - A system and method for performing a floating function in an earthmoving implement of an earthmoving machine without physically connecting chambers within a hydraulic actuator that is adapted to raise and lower the earthmoving implement. The system includes a device for delivering a pressurized fluid to and receiving pressurized fluid from the actuator, a valve for compensating for differences in volume between chambers of the actuator, and an electronic control circuit that includes electronic sensors for sensing the pressures in the chambers of the actuator, and a controller for receiving outputs of the sensors. The controller calculates an amount of the pressurized fluid that, when delivered to or received from the actuator, achieves a substantially constant pressures in the chambers of the actuator and enables the earthmoving implement to float regardless of motion of the actuator. | 07-01-2010 |
20100163258 | SYSTEM AND METHOD FOR BLADE LEVEL CONTROL OF EARTHMOVING MACHINES - A system for automatically controlling the position and level of an earthmoving implement on an earthmoving machine. The system includes at least one hydraulic actuator adapted to raise and lower the earthmoving implement, a device for delivering a pressurized fluid to and receiving pressurized fluid from the actuator, and an electronic control circuit that includes electronic sensors for sensing the absolute orientation of the machine and the position of the actuator, and a controller for receiving outputs of the sensors, calculating an amount of the pressurized fluid that must be delivered to or received from the actuator to achieve a desired position for the earthmoving implement, and control the delivering-receiving device to deliver or receive the amount of the pressurized fluid to achieve the desired position for the earthmoving implement. | 07-01-2010 |
Patent application number | Description | Published |
20100210815 | Insulin production methods and pro-insulin constructs - Novel pro-insulin having specific amino acid and/or nucleic acid modifications suitable for improved methods of insulin production are provided. Novel and highly efficient processes for preparing the pro-insulin preparations and preparations containing them are also disclosed. The novel pro-insulin preparations may be converted into human insulin useful in therapeutic preparations. Novel peptides of the C-peptide, and N terminus, including RREAEALQVGQVELGGGPGAGSLQPLALEGSLQAR (SEQ ID NO:32), and MHHHHHHGGR (SEQ ID NO:36) respectively are provided, as well as the unique nucleic acid molecules encoding them. | 08-19-2010 |
20120214199 | LIS-PRO PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING LIS-PRO INSULIN ANALOGS THEREFROM - Lis-Pro modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification are presented. Methods for producing Lis-Pro insulin analogs are also disclosed. Highly efficient processes for preparing the Lis-Pro insulin analogs and improved preparations containing the Lis-Pro insulin analogs prepared according to the methods described herein are also provided. | 08-23-2012 |
20120214963 | ASPART PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING ASPART INSULIN ANALOGS THEREFROM - Aspart modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification for producing aspart insulin analogs are provided. Highly efficient processes for preparing the aspart insulin analogs and improved preparations containing the aspart insulin analogs prepared according to the methods described herein are also provided. | 08-23-2012 |
20120214964 | LIQUID INSULIN COMPOSITIONS AND METHODS OF MAKING THE SAME - Disclosed herein are novel and improved preparations and methods for manufacturing substantially liquid preparations of recombinant human insulin API. The purified recombinant human insulin Active Pharmaceutical Ingredient (API) preparations are substantially free of by-products associated with the lyophilization and/or crystallization. The methods for manufacturing the substantially liquid recombinant human insulin API preparations are provided with optional steps for subjecting the recombinant insulin preparation to lyophilization and/or crystallization. Enhanced yield of recombinant insulin of greater purity are thereby provided according to the present invention. Highly purified formulations of recombinant human insulin of the API insulin preparations disclosed herein are also provided. Stably transformed | 08-23-2012 |
20120214965 | GLARGINE PROINSULIN AND METHODS OF PRODUCING GLARGINE INSULIN ANALOGS THEREFROM - Glargine proinsulin sconstructs that have a modified C-peptide amino acid and/or nucleic acid sequence for producing glargine insulin analogs are provided. Highly efficient processes for preparing the glargine insulin analogs and improved preparations containing the glargine insulin analogs prepared according to the methods described herein are also provided. | 08-23-2012 |
20130210716 | LIS-PRO PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING LIS-PRO INSULIN ANALOGS THEREFROM - Lis-Pro modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification are presented. Methods for producing Lis-Pro insulin analogs are also disclosed. Highly efficient processes for preparing the Lis-Pro insulin analogs and improved preparations containing the Lis-Pro insulin analogs prepared according to the methods described herein are also provided. | 08-15-2013 |
20140213514 | INSULIN PRODUCTION METHODS AND PRO-INSULIN CONSTRUCTS - Novel pro-insulin having specific amino acid and/or nucleic acid modifications suitable for improved methods of insulin production are provided. Novel and highly efficient processes for preparing the pro-insulin preparations and preparations containing them are also disclosed. The novel pro-insulin preparations may be converted into human insulin useful in therapeutic preparations. Novel peptides of the C-peptide, and N terminus, including RREAEALQVGQVELGGGPGAGSLQPLALEGSLQAR, and MHHHHHHGGR respectively are provided, as well as the unique nucleic acid molecules encoding them. | 07-31-2014 |
20140213756 | LIQUID INSULIN COMPOSITIONS AND METHODS OF MAKING THE SAME - Disclosed herein are novel and improved preparations and methods for manufacturing substantially liquid preparations of recombinant human insulin API. The purified recombinant human insulin Active Pharmaceutical Ingredient (API) preparations are substantially free of by-products associated with the lyophilization and/or crystallization. The methods for manufacturing the substantially liquid recombinant human insulin API preparations are provided with optional steps for subjecting the recombinant insulin preparation to lyophilization and/or crystallization. Enhanced yield of recombinant insulin of greater purity are thereby provided according to the present invention. Highly purified formulations of recombinant human insulin of the API insulin preparations disclosed herein are also provided. Stably transformed | 07-31-2014 |
20140221606 | Aspart Proinsulin Compositions and Methods of Producing Aspart Insulin Analogs - Aspart modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification for producing aspart insulin analogs are provided. Highly efficient processes for preparing the aspart insulin analogs and improved preparations containing the aspart insulin analogs prepared according to the methods described herein are also provided. | 08-07-2014 |
20160024168 | ASPART PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING ASPART INSULIN ANALOGS - Aspart modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification for producing aspart insulin analogs are provided. Highly efficient processes for preparing the aspart insulin analogs and improved preparations containing the aspart insulin analogs prepared according to the methods described herein are also provided. | 01-28-2016 |
20160030520 | LIQUID INSULIN COMPOSITIONS AND METHODS OF MAKING THE SAME - Disclosed herein are novel and improved preparations and methods for manufacturing substantially liquid preparations of recombinant human insulin API. The purified recombinant human insulin Active Pharamaceutical Ingredient (API) preparations are substantially free of by-products associated with the lyophilization and/or crystallization. The methods for manufacturing the substantially liquid recombinant human insulin API preparations are provided with optional steps for subjecting the recombinant insulin preparation to lyophilization and/or crystallization. Enhanced yield of recombinant insulin of greater purity are thereby provided according to the present invention. Highly purified formulations of recombinant human insulin of the API insulin preparations disclosed herein are also provided. Stably transformed | 02-04-2016 |
20160039899 | LIS-PRO PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING LIS-PRO INSULIN ANALOGS THEREFROM - Lis-Pro modified proinsulin sequences that have a modified C-peptide amino acid and/or nucleic acid modification are presented. Methods for producing Lis-Pro insulin analogs are also disclosed. Highly efficient processes for preparing the Lis-Pro insulin analogs and improved preparations containing the Lis-Pro insulin analogs prepared according to the methods described herein are also provided. | 02-11-2016 |
Patent application number | Description | Published |
20100042167 | ORTHOPAEDIC SCREWS - An orthopaedic screw having a plurality of regions, at least one of which may be porous. The orthopaedic screw includes a head, a tip and at least one thread. The porosity of the screw of the present invention can vary within the part or region, including changes in pore shape, size and density. These characteristics can vary along the length of the screw axis and/or radially (from the outer diameter to the axis). The orthopaedic screw may further include at least one solid region formed of any implantable polymer, reinforced polymer or metal. | 02-18-2010 |
20100042213 | DRUG DELIVERY IMPLANTS - An orthopaedic implant system includes an orthopaedic implant implantable at a selected location within a corporeal body and configured for delivering at least one therapeutic agent to the corporeal body. The implant includes a reservoir and a plurality of channels. The reservoir is configured for receiving the at least one therapeutic agent. The plurality of channels are configured for conveying the at least one therapeutic agent from the reservoir to a treatment site relative to the corporeal body. | 02-18-2010 |
20100042214 | DRUG DELIVERY IMPLANTS - An orthopaedic implant system includes an orthopaedic implant implantable at a selected location within a corporeal body and configured for delivering at least one therapeutic agent to the corporeal body, the implant defining a reservoir and a plurality of channels, the reservoir configured for receiving the at least one therapeutic agent, the plurality of channels configured for conveying the at least one therapeutic agent from the reservoir to a treatment site relative to the corporeal body, the implant being at least one of an internal fixation device and a porous device. | 02-18-2010 |
20100042215 | ORTHOPAEDIC IMPLANT - An orthopaedic implant system includes an orthopaedic implant implantable at a selected location within a corporeal body. The implant includes a first structural material and a second structural material. The first structural material is non-resorbable relative to the corporeal body and is different relative to the second structural material. The implant is an internal fixation device. | 02-18-2010 |
20100042218 | ORTHOPAEDIC IMPLANT WITH POROUS STRUCTURAL MEMBER - An orthopaedic implant includes a first member comprised of a substantially non-porous material, and a second member coupled with the first member. The second member has a first side and an opposing second side, with each of the first side and the second side being external load bearing surfaces. The second member is formed from a substantially porous material with interconnecting pores extending from the first side to the second side. | 02-18-2010 |
20100042226 | ORTHOPAEDIC IMPLANT WITH SPATIALLY VARYING POROSITY - An orthopaedic implant includes a body member having a first region with a first porosity and a second region with a second porosity. At least one physical characteristic of the first porosity is different than at least one physical characteristic of the second porosity. | 02-18-2010 |
20130253473 | ORTHOPAEDIC SCREWS - An orthopaedic screw having a plurality of regions, at least one of which may be porous. The orthopaedic screw includes a head, a tip and at least one thread. The porosity of the screw of the present invention can vary within the part or region, including changes in pore shape, size and density. These characteristics can vary along the length of the screw axis and/or radially (from the outer diameter to the axis). The orthopaedic screw may further include at least one solid region formed of any implantable polymer, reinforced polymer or metal. | 09-26-2013 |
20150038941 | DRUG DELIVERY IMPLANTS - An orthopaedic implant system includes an external fixation device implantable at a selected location within a corporeal body and configured for delivering at least one therapeutic agent to the corporeal body. The external fixation device includes an implantable pin, a sheath coupled with the pin, a reservoir coupled with the sheath and a plurality of channels. The pin defines the plurality of channels. The reservoir is configured for receiving the at least one therapeutic agent. The plurality of channels are configured for conveying the at least one therapeutic agent from the reservoir to a treatment site relative to the corporeal body. | 02-05-2015 |
Patent application number | Description | Published |
20090070261 | SYSTEM FOR IDENTIFYING AN INDIVIDUAL AND MANAGING AN ACCOUNT - The present invention provides a method for managing an account for an unidentified individual by communicating with the unidentified individual who is using a device to communicate which transmits an identifier associated with the origin of the communication, obtaining from the unidentified individual a group of characters associated with the unidentified individual's personal information, comparing the group of characters to a database including a plurality of personal information associated with a plurality of individuals, identifying from the plurality of individuals one individual whose plurality of personal information includes the group of characters associated with the unidentified individual, and managing an account for the identified individual in an account database. | 03-12-2009 |
20090319383 | SYSTEM FOR IDENTIFYING AN INDIVIDUAL AND MANAGING AN ACCOUNT - The present invention provides a method for managing an account for an unidentified individual by communicating with the unidentified individual who is using a device to communicate which transmits an identifier associated with the origin of the communication, obtaining from the unidentified individual a group of characters associated with the unidentified individual's personal information, comparing the group of characters to a database including a plurality of personal information associated with a plurality of individuals, identifying from the plurality of individuals one individual whose plurality of personal information includes the group of characters associated with the unidentified individual, and managing an account for the identified individual in an account database. | 12-24-2009 |
20120226576 | Method and System for Conducting a Silent Auction - A method for conducting a silent auction using software that communicates via text/SMS messaging with a bidder's personal mobile phone devices using the bidder's wireless service provider. The auction management software may be effective for managing and conducting multiple auctions simultaneously. | 09-06-2012 |